BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Safety notice for insulin pumps DANA Diabecare IIS, Sooil Development Co. Ltd

Product group Injections / Infusions / Transfusions / Dialysis - infusion technology
Reference 02825/13

Sooil Development Co. Ltd has issued a field safety notice concerning necessary modification of user instructions and of the minimal basal rate setting in insulin pumps DANA Diabecare IIS of certain serial identification and manufacturing period.

Safety notice for insulin pumps DANA Diabecare IIS, Sooil Development Co. Ltd , Download_VeroeffentlichtAm_EN PDF, 727KB, File does not meet accessibility standards